DGAP-News

co.don Aktiengesellschaft: co.don AG announces results of ordinary shareholders' meeting for 2016

DGAP-News: co.don Aktiengesellschaft / Key word(s): AGM/EGM
co.don Aktiengesellschaft: co.don AG announces results of ordinary
shareholders' meeting for 2016

19.07.2016 / 11:00
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Press release

co.don AG announces results of ordinary shareholders' meeting for 2016

Teltow/Berlin, 19.07.2016 - This year's shareholders' meeting of co.don AG
(ISIN DE000A1K0227) was held in Berlin on 14 July 2016. The shareholders
attending, who represented 46.5% of the 16.2 million voting shares,
approved all the proposals put forward by company management.

Dirk Hessel, CEO of co.don AG, reported on the financial year 2015 and the
course of business in the first half of 2016. "2015 was an important year
for co.don AG. For one thing it was the most successful year in the
company's history to date, and for another, 2015 was the year the
transformation of co.don AG began. A biotech company focused on research
and development is now becoming a fully integrated, biopharmaceuticals
company and part of the Mittelstand. In 2015 the company increased its
revenues year on year by 13.6%", said Hessel. "The financial year 2016 also
started well for co.don, with rapid revenue growth of 23% in the first
quarter compared with the same period a year ago. The ongoing success of
the company's restructuring and its preparations for EU market entry mean
the company is well on track. The portfolio and market presence of
Bauerfeind AG, our new anchor shareholder, also open up new opportunities
for the company's international expansion and commercialisation."

The members of the Executive Board and Supervisory Board were exonerated
for the financial year 2015. Roever Broenner Susat Mazars GmbH & Co. KG
Wirtschaftsprüfungs- und Steuerberatungsgesellschaft, Hamburg, was
appointed as auditor for 2016. New Supervisory Board elections were
required, since the terms of office of Prof. Dr Barbara Sickmüller and Dr
Bernd Wegener ended at the close of the shareholders' meeting on 14 July
2016. Dr Bernd Wegener and Prof. Dr Barbara Sickmüller were re-elected to
the Supervisory Board. Mr Pettersen and Mr Talyanskiy resigned their
Supervisory Board seats as of 15 August 2016. Shareholders approved the
proposal by the former major shareholder OSEMIFARO to elect Professor Hans
Bauerfeind and Ms Beatrix Bauerfeind-Johnson to the Supervisory Board with
effect from 16 August 2016.

About co.don(R) AG: Berlin-based co.don AG develops, produces and markets
in Germany autologous cell therapies for the minimally invasive repair of
cartilage damage to joints following traumatic or degenerative defects.
co.don condrosphere(R) is a cell therapy product that uses only the
patient's own cartilage cells ("autologous chondrocytes"). co.don
condrosphere(R) has been approved by the German federal agency PEI in
accordance with Section 4b of the German Pharmaceuticals Act (AMG) and is
currently undergoing Phase II and III clinical trials to obtain European
marketing authorisation. co.don condrosphere(R) has been used for more than
10 years in over 120 clinics to treat more than 10,000 patients. In Germany
the statutory health insurance companies have paid for the treatment of
knee and hip joints since 2007 and for the treatment of vertebral joints
since 2008. The shares in co.don AG are listed on the Frankfurt Stock
Exchange (ISIN: DE000A1K0227). Executive Board: Dirk Hessel (CEO), Ralf
M. Jakobs (CFO), Vilma Methner (COO, CSO). More information is available at
www.ihre-zellzuechter.de or www.codon.de

Press contact

Matthias Meißner, M.A.
Corporate communications / IR / PR
+49 [phone]
Fax: [phone]
[e-mail]




---------------------------------------------------------------------------

19.07.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: co.don Aktiengesellschaft
Warthestraße 21
14513 Teltow
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.codon.de
ISIN: DE000A1K0227
WKN: A1K022
Listed: Regulated Market in Frankfurt (General Standard);
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart, Tradegate Exchange


End of News DGAP News Service
---------------------------------------------------------------------------

483685 19.07.2016